Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John H Healey

Showing results (221-230 of 241) with videos related to

Pageof 25
Sort By:
Cancer Research|January 10, 2002
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patientsMarc Ladanyi, Cristina R Antonescu, Denis H Leung, et al.
Nature Communications|February 10, 2016
Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancerPasquale Sansone, Claudio Ceccarelli, Marjan Berishaj, et al.
Science (New York, N.Y.)|February 26, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumorsSophie A Hanina, Tyler Park, Michael Lopez, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial LocalizationNir Ben-Chetrit, Xiang Niu, Jesus Sotelo, et al.
Clinical Therapeutics|April 5, 2016
Patient-reported Symptoms of Tenosynovial Giant Cell TumorsHeather L Gelhorn, Sandra Tong, Kelly McQuarrie, et al.
The Oncologist|October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue SarcomasRodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
Lancet (London, England)|June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCTWilliam D Tap, Arun S Singh, Stephen Patrick Anthony, et al.
NPJ Breast Cancer|May 25, 2021
Anti-tumor effects of an ID antagonist with no observed acquired resistancePaulina M Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Pageof 25

Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Cancer Research|January 10, 2002
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patientsMarc Ladanyi, Cristina R Antonescu, Denis H Leung, et al.
Nature Communications|February 10, 2016
Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancerPasquale Sansone, Claudio Ceccarelli, Marjan Berishaj, et al.
Science (New York, N.Y.)|February 26, 2026
Sensitive CAR T cells redefine targetable CD70 expression in solid tumorsSophie A Hanina, Tyler Park, Michael Lopez, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Breast Cancer Macrophage Heterogeneity and Self-renewal are Determined by Spatial LocalizationNir Ben-Chetrit, Xiang Niu, Jesus Sotelo, et al.
Clinical Therapeutics|April 5, 2016
Patient-reported Symptoms of Tenosynovial Giant Cell TumorsHeather L Gelhorn, Sandra Tong, Kelly McQuarrie, et al.
The Oncologist|October 10, 2015
A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue SarcomasRodrigo R Munhoz, Sandra P D'Angelo, Mrinal M Gounder, et al.
Lancet (London, England)|June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCTWilliam D Tap, Arun S Singh, Stephen Patrick Anthony, et al.
NPJ Breast Cancer|May 25, 2021
Anti-tumor effects of an ID antagonist with no observed acquired resistancePaulina M Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Pageof 25